Standout Papers

Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis 2024 202631
  1. Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis (2024)
    Patrik Nasr, Axel Wester et al. Clinical Gastroenterology and Hepatology
  2. Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes (2024)
    Axel Wester, Ying Shang et al. Gut

Immediate Impact

1 from Science/Nature 33 standout
Sub-graph 1 of 13

Citing Papers

GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease
2024 Standout
Epidemiology of metabolic dysfunction-associated steatotic liver disease
2024 Standout
1 intermediate paper

Works of Axel Wester being referenced

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes
2024 Standout
Effect of common genetic variants on the risk of cirrhosis in non‐alcoholic fatty liver disease during 20 years of follow‐up
2022

Author Peers

Author Last Decade Papers Cites
Axel Wester 191 95 103 36 339
Rosa Cannistraci 183 84 61 23 386
Taiba Zornitzki 197 61 72 26 393
Altay Çelebi 171 35 130 34 336
Hangkai Huang 224 59 67 30 377
Emanuele Muraca 241 102 46 23 401
Felipe David Mendonça Chaim 164 42 165 39 302
Masayuki Kishida 117 81 96 39 398
Nicola Napoli 171 138 67 34 374
Jiarong Xie 177 39 101 39 400
C Pozzato 138 46 103 24 317

All Works

Loading papers...

Rankless by CCL
2026